New Drug Development and Clinical Trial Design by Applying Genomic Information Management.
Ontology highlight
ABSTRACT: Depending on the patients' genotype, the same drug may have different efficacies or side effects. With the cost of genomic analysis decreasing and reliability of analysis methods improving, vast amount of genomic information has been made available. Several studies in pharmacology have been based on genomic information to select the optimal drug, determine the dose, predict efficacy, and prevent side effects. This paper reviews the tissue specificity and genomic information of cancer. If the tissue specificity of cancer is low, cancer is induced in various organs based on a single gene mutation. Basket trials can be performed for carcinomas with low tissue specificity, confirming the efficacy of one drug for a single gene mutation in various carcinomas. Conversely, if the tissue specificit
SUBMITTER: Ko YK
PROVIDER: S-EPMC9330622 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA